MicroPort CardioFlow Medtech Corporation

Informe acción SEHK:2160

Capitalización de mercado: HK$2.0b

MicroPort CardioFlow Medtech Dirección

Dirección controles de criterios 2/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Jeffrey R Lindstrom

Chief Executive Officer (CEO)

CN¥4.0m

Compensación total

Porcentaje del salario del CEO59.8%
Permanencia del CEO1.1yrs
Participación del CEOn/a
Permanencia media de la dirección3.9yrs
Promedio de permanencia en la Junta Directiva3.7yrs

Actualizaciones recientes de la dirección

Recent updates

MicroPort CardioFlow Medtech Corporation (HKG:2160) Stocks Shoot Up 34% But Its P/S Still Looks Reasonable

Sep 27
MicroPort CardioFlow Medtech Corporation (HKG:2160) Stocks Shoot Up 34% But Its P/S Still Looks Reasonable

After Leaping 34% MicroPort CardioFlow Medtech Corporation (HKG:2160) Shares Are Not Flying Under The Radar

Sep 27
After Leaping 34% MicroPort CardioFlow Medtech Corporation (HKG:2160) Shares Are Not Flying Under The Radar

Are Investors Undervaluing MicroPort CardioFlow Medtech Corporation (HKG:2160) By 43%?

Aug 07
Are Investors Undervaluing MicroPort CardioFlow Medtech Corporation (HKG:2160) By 43%?

Some MicroPort CardioFlow Medtech Corporation (HKG:2160) Shareholders Look For Exit As Shares Take 26% Pounding

Jun 19
Some MicroPort CardioFlow Medtech Corporation (HKG:2160) Shareholders Look For Exit As Shares Take 26% Pounding

MicroPort CardioFlow Medtech (HKG:2160) Is In A Good Position To Deliver On Growth Plans

May 29
MicroPort CardioFlow Medtech (HKG:2160) Is In A Good Position To Deliver On Growth Plans

MicroPort CardioFlow Medtech Corporation (HKG:2160) Shares May Have Slumped 29% But Getting In Cheap Is Still Unlikely

Apr 05
MicroPort CardioFlow Medtech Corporation (HKG:2160) Shares May Have Slumped 29% But Getting In Cheap Is Still Unlikely

We Think MicroPort CardioFlow Medtech (HKG:2160) Can Afford To Drive Business Growth

Feb 23
We Think MicroPort CardioFlow Medtech (HKG:2160) Can Afford To Drive Business Growth

An Intrinsic Calculation For MicroPort CardioFlow Medtech Corporation (HKG:2160) Suggests It's 37% Undervalued

Jan 18
An Intrinsic Calculation For MicroPort CardioFlow Medtech Corporation (HKG:2160) Suggests It's 37% Undervalued

Companies Like MicroPort CardioFlow Medtech (HKG:2160) Are In A Position To Invest In Growth

Oct 04
Companies Like MicroPort CardioFlow Medtech (HKG:2160) Are In A Position To Invest In Growth

Not Many Are Piling Into MicroPort CardioFlow Medtech Corporation (HKG:2160) Stock Yet As It Plummets 27%

May 31
Not Many Are Piling Into MicroPort CardioFlow Medtech Corporation (HKG:2160) Stock Yet As It Plummets 27%

We Think MicroPort CardioFlow Medtech (HKG:2160) Can Afford To Drive Business Growth

May 23
We Think MicroPort CardioFlow Medtech (HKG:2160) Can Afford To Drive Business Growth

The MicroPort CardioFlow Medtech Corporation (HKG:2160) Analysts Have Been Trimming Their Sales Forecasts

Apr 06
The MicroPort CardioFlow Medtech Corporation (HKG:2160) Analysts Have Been Trimming Their Sales Forecasts

MicroPort CardioFlow Medtech (HKG:2160) Is In A Good Position To Deliver On Growth Plans

Feb 08
MicroPort CardioFlow Medtech (HKG:2160) Is In A Good Position To Deliver On Growth Plans

We Think MicroPort CardioFlow Medtech (HKG:2160) Can Afford To Drive Business Growth

Oct 18
We Think MicroPort CardioFlow Medtech (HKG:2160) Can Afford To Drive Business Growth

We're Not Very Worried About MicroPort CardioFlow Medtech's (HKG:2160) Cash Burn Rate

Jun 30
We're Not Very Worried About MicroPort CardioFlow Medtech's (HKG:2160) Cash Burn Rate

Analysts Just Made A Major Revision To Their MicroPort CardioFlow Medtech Corporation (HKG:2160) Revenue Forecasts

Apr 04
Analysts Just Made A Major Revision To Their MicroPort CardioFlow Medtech Corporation (HKG:2160) Revenue Forecasts

MicroPort CardioFlow Medtech Corporation (HKG:2160) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

Apr 03
MicroPort CardioFlow Medtech Corporation (HKG:2160) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

An Intrinsic Calculation For MicroPort CardioFlow Medtech Corporation (HKG:2160) Suggests It's 49% Undervalued

Jan 21
An Intrinsic Calculation For MicroPort CardioFlow Medtech Corporation (HKG:2160) Suggests It's 49% Undervalued

Are Investors Undervaluing MicroPort CardioFlow Medtech Corporation (HKG:2160) By 24%?

Sep 05
Are Investors Undervaluing MicroPort CardioFlow Medtech Corporation (HKG:2160) By 24%?

We're Not Worried About MicroPort CardioFlow Medtech's (HKG:2160) Cash Burn

Jun 07
We're Not Worried About MicroPort CardioFlow Medtech's (HKG:2160) Cash Burn

Market Sentiment Around Loss-Making MicroPort CardioFlow Medtech Corporation (HKG:2160)

May 03
Market Sentiment Around Loss-Making MicroPort CardioFlow Medtech Corporation (HKG:2160)

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Jeffrey R Lindstrom en comparación con los beneficios de MicroPort CardioFlow Medtech?
FechaCompensación totalSalarioIngresos de la empresa
Jun 30 2024n/an/a

-CN¥349m

Mar 31 2024n/an/a

-CN¥410m

Dec 31 2023CN¥4mCN¥2m

-CN¥472m

Compensación vs. Mercado: La compensación total de Jeffrey R($USD561.58K) está por encima de la media de empresas de tamaño similar en el mercado Hong Kong ($USD371.43K).

Compensación vs. Ingresos: Datos insuficientes para comparar la compensación de Jeffrey R con los resultados de la empresa.


CEO

Jeffrey R Lindstrom (57 yo)

1.1yrs

Permanencia

CN¥4,004,000

Compensación

Mr. Jeffrey R Lindstrom is President, Executive Director & General Manager of MicroPort CardioFlow Medtech Corporation from August 29, 2023. He served as senior director of engineering in Edwards Lifescien...


Equipo directivo

NombrePosiciónPermanenciaCompensaciónPropiedad
Jeffrey R Lindstrom
President1.1yrsCN¥4.00msin datos
Liang Zhao
Executive Director & First VP of Total Solutions2.3yrsCN¥3.91m0.058%
CN¥ 1.2m
Luying Yan
VP & Executive Director4yrsCN¥2.70m0.042%
CN¥ 840.2k
Xiangmei Li
Joint Company Secretary3.9yrssin datossin datos
Lok Yee Chan
Joint Company Secretary3.9yrssin datossin datos

3.9yrs

Permanencia media

43yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de 2160 se considera experimentado (3.8 años antigüedad media).


Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
Jeffrey R Lindstrom
President1.1yrsCN¥4.00msin datos
Liang Zhao
Executive Director & First VP of Total Solutions2.3yrsCN¥3.91m0.058%
CN¥ 1.2m
Luying Yan
VP & Executive Director4yrsCN¥2.70m0.042%
CN¥ 840.2k
Jonathan H. Chou
Independent Non-Executive Director3.7yrsCN¥254.00ksin datos
Xia Wu
Non-Executive Director5.1yrssin datossin datos
Guoming Chen
Non-Executive Chairman of the Board4yrsCN¥3.16m0.031%
CN¥ 616.6k
Junjie Zhang
Non-Executive Director5.1yrssin datossin datos
Zhixiang Sun
Independent Non-Executive Director3.7yrsCN¥254.00ksin datos
Jiandong Ding
Independent Non-Executive Director3.1yrsCN¥254.00k0.0012%
CN¥ 24.8k

3.7yrs

Permanencia media

47yo

Promedio de edad

Junta con experiencia: La junta directiva de 2160 se considera experimentada (3.6 años de antigüedad promedio).